JP2023156197A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023156197A5 JP2023156197A5 JP2022065934A JP2022065934A JP2023156197A5 JP 2023156197 A5 JP2023156197 A5 JP 2023156197A5 JP 2022065934 A JP2022065934 A JP 2022065934A JP 2022065934 A JP2022065934 A JP 2022065934A JP 2023156197 A5 JP2023156197 A5 JP 2023156197A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- replaced
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 114
- 150000001413 amino acids Chemical class 0.000 claims 70
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 241001678559 COVID-19 virus Species 0.000 claims 4
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims 4
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 2
- 208000025721 COVID-19 Diseases 0.000 claims 1
- 101710141454 Nucleoprotein Proteins 0.000 claims 1
- 208000037847 SARS-CoV-2-infection Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022065934A JP2023156197A (ja) | 2022-04-12 | 2022-04-12 | ＳＡＲＳ－ＣｏＶ－２結合ペプチド |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022065934A JP2023156197A (ja) | 2022-04-12 | 2022-04-12 | ＳＡＲＳ－ＣｏＶ－２結合ペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023156197A JP2023156197A (ja) | 2023-10-24 |
| JP2023156197A5 true JP2023156197A5 (cg-RX-API-DMAC7.html) | 2025-04-02 |
Family
ID=88421226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022065934A Pending JP2023156197A (ja) | 2022-04-12 | 2022-04-12 | ＳＡＲＳ－ＣｏＶ－２結合ペプチド |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2023156197A (cg-RX-API-DMAC7.html) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021221136A1 (ja) * | 2020-05-01 | 2021-11-04 | 花王株式会社 | 抗ＳＡＲＳ－ＣｏＶ－２抗体 |
-
2022
- 2022-04-12 JP JP2022065934A patent/JP2023156197A/ja active Pending